{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:51:49Z","timestamp":1782489109432,"version":"3.54.5"},"posted":{"date-parts":[[2026,6,24]]},"group-title":"Neurology","reference-count":26,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Tokyo Metropolitan Government Program for Supporting Antibody Therapies for Dementia","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP24dk0207068"],"award-info":[{"award-number":["JP24dk0207068"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP25dk0207075"],"award-info":[{"award-number":["JP25dk0207075"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP24K10653"],"award-info":[{"award-number":["JP24K10653"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP25K19014"],"award-info":[{"award-number":["JP25K19014"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>INTRODUCTION<\/jats:title>\n                  <jats:p>Anti-amyloid therapy eligibility excludes patients with five or more cerebral microhemorrhages (CMHs), but current guidance allows either T2*-GRE or the more sensitive SWI. This may create sequence-dependent differences in eligibility classification.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>\n                    We fitted a Bayesian right-censored zero-inflated Poisson model to single-center real-world SWI-based CMH counts from 130 memory clinic patients. We then simulated T2*-GRE counts under a directional binomial detection model across a range of relative detection probabilities and estimated two metrics:\n                    <jats:italic>P(T2* &lt;5 | SWI<\/jats:italic>\n                    \u2265\n                    <jats:italic>5)<\/jats:italic>\n                    and\n                    <jats:italic>P(SWI<\/jats:italic>\n                    \u2265\n                    <jats:italic>5 | T2* &lt;5)<\/jats:italic>\n                    .\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The model estimated a zero-inflation probability of 0.57 and a Poisson mean of 2.29 in the susceptible subpopulation. In the illustrative 60% relative-detection scenario, the model estimated nearly 80% under-detection among SWI-ineligible patients, whereas approximately 5% of T2*-GRE-eligible patients would have been classified as ineligible by SWI.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>DISCUSSION<\/jats:title>\n                  <jats:p>A uniform numeric CMH threshold may not be operationally equivalent across SWI and T2*-GRE. Standardized paired-sequence outcome studies are needed to determine whether SWI-defined and T2*-GRE-defined thresholds carry equivalent ARIA risk.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.22.26356283","type":"posted-content","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:55:16Z","timestamp":1782356116000},"source":"Crossref","is-referenced-by-count":0,"title":["SWI and T2*-GRE Microhemorrhage Counts in Anti-Amyloid Therapy Eligibility: A Real-World-Calibrated Simulation Study"],"prefix":"10.64898","author":[{"given":"Kenichiro","family":"Sato","sequence":"first","affiliation":[{"name":"Dementia Inclusion and Therapeutics, The University of Tokyo Hospital"},{"name":"Healthy Aging Innovation Center, Tokyo Metropolitan Institute for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-3283","authenticated-orcid":false,"given":"Ryoko","family":"Ihara","sequence":"additional","affiliation":[{"name":"Healthy Aging Innovation Center, Tokyo Metropolitan Institute for Geriatrics and Gerontology"},{"name":"Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology"},{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Tokumaru","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Tokyo Metropolitan Institute for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Niimi","sequence":"additional","affiliation":[{"name":"Dementia Inclusion and Therapeutics, The University of Tokyo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwatsubo","sequence":"additional","affiliation":[{"name":"Dementia Inclusion and Therapeutics, The University of Tokyo Hospital"},{"name":"National Center of Neurology and Psychiatry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Healthy Aging Innovation Center, Tokyo Metropolitan Institute for Geriatrics and Gerontology"},{"name":"Integrated Research Initiative for Living Well with Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology"},{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026062608270821000_2026.06.22.26356283v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"2026062608270821000_2026.06.22.26356283v1.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"2026062608270821000_2026.06.22.26356283v1.3","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7586"},{"key":"2026062608270821000_2026.06.22.26356283v1.4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad188"},{"key":"2026062608270821000_2026.06.22.26356283v1.5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.0065"},{"key":"2026062608270821000_2026.06.22.26356283v1.6","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.30"},{"key":"2026062608270821000_2026.06.22.26356283v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100150"},{"key":"2026062608270821000_2026.06.22.26356283v1.8","unstructured":"Ministry of Health, Labour and Welfare, Japan. Optimal Use Promotion Guideline: lecanemab (genetical recombination) [in Japanese]. 2023. Available from: https:\/\/www.mhlw.go.jp\/content\/12404000\/001178607.pdf."},{"key":"2026062608270821000_2026.06.22.26356283v1.9","unstructured":"Ministry of Health, Labour and Welfare, Japan. Optimal Use Promotion Guideline: donanemab (genetical recombination) [in Japanese]. Revised August 2025. Available from: https:\/\/www.mhlw.go.jp\/content\/10808000\/001330899.pdf"},{"key":"2026062608270821000_2026.06.22.26356283v1.10","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.14945"},{"key":"2026062608270821000_2026.06.22.26356283v1.11","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71361"},{"key":"2026062608270821000_2026.06.22.26356283v1.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-025-01773-x"},{"key":"2026062608270821000_2026.06.22.26356283v1.13","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1355"},{"key":"2026062608270821000_2026.06.22.26356283v1.14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.002267"},{"key":"2026062608270821000_2026.06.22.26356283v1.15","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4248"},{"key":"2026062608270821000_2026.06.22.26356283v1.16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203071"},{"key":"2026062608270821000_2026.06.22.26356283v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100220"},{"key":"2026062608270821000_2026.06.22.26356283v1.18","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70652"},{"key":"2026062608270821000_2026.06.22.26356283v1.19","unstructured":"Svaldi DO , Biffi A , Wang H , Monkul Nery ES , Gao C , Lu M , Collins EC , Feakins K , Shcherbinin S , Brooks D , Sims J . Head-to-head comparison of SWI and T2*-weighted gradient echo MRI sequences to detect ARIA-H in the TRAILBLAZER-ALZ 6 trial of donanemab. Conference slide presentation. Clinical Trials on Alzheimer\u2019s Disease (CTAD) 2025; 2025. Available from: https:\/\/lillyscience.lilly.com\/congress\/ctad2025."},{"key":"2026062608270821000_2026.06.22.26356283v1.20","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70315"},{"key":"2026062608270821000_2026.06.22.26356283v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2005.06.003"},{"key":"2026062608270821000_2026.06.22.26356283v1.22","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.21049"},{"key":"2026062608270821000_2026.06.22.26356283v1.23","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14162"},{"key":"2026062608270821000_2026.06.22.26356283v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2023.10.008"},{"key":"2026062608270821000_2026.06.22.26356283v1.25","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01568-8"},{"key":"2026062608270821000_2026.06.22.26356283v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-025-00980-5"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.22.26356283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:27:22Z","timestamp":1782487642000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.06.22.26356283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":26,"URL":"https:\/\/doi.org\/10.64898\/2026.06.22.26356283","relation":{},"subject":[],"published":{"date-parts":[[2026,6,24]]},"subtype":"preprint"}}